Dr Reddy's Announces Commercial Launch Of Covid Drug 2-DG, Caps Price
Dr Reddy’s Announces Commercial Launch Of Covid Drug 2-DG, Caps Price
The 2-DG drug was approved for emergency use in COVID-19 patients on May 1 New Delhi: Dr Reddy’s Laboratories today announced the commercial launch of 2-Deoxy-D-Glucose (2-DG) used to treat Covid patients, adding that the drug will be available across hospitals in metros and Tier 1 cities in the initial weeks. The drug, developed by DRDO and Dr Reddy’s Laboratories, has been found to help speed…
View On WordPress















